Zinc has the best evidence of any supplement for shortening the common cold, which is a lower bar than it sounds. The effect is real in several trials, modest in size, and dependent on details that most people taking zinc get wrong.
What do the trials show?
Meta-analyses pooling randomised trials of zinc lozenges have generally found a reduction in cold duration of around one to two days compared with placebo.
The trials are heterogeneous, meaning they varied considerably in dose, form and design, and reviewers have repeatedly noted that this makes a confident summary difficult. Some individual trials found no effect at all.
The findings that are positive share three features: treatment started within about 24 hours of symptoms appearing, a high daily dose, and a form that releases free zinc ions in the mouth.
Why does the timing matter so much?
The proposed mechanism involves zinc ions interfering with rhinovirus replication and with the virus binding to cells in the nasal passages.
By the time symptoms are well established, viral replication has largely happened and the symptoms you feel are your own immune response rather than the virus itself. Intervening at that point has much less to work with.
Practically this means keeping lozenges in the house rather than buying them on day three, by which point the useful window has closed.
What dose was used?
Trials showing benefit generally used at least 75 milligrams of elemental zinc a day, divided into lozenges taken every two to three hours while awake.
That is far above the reference intake of around 7 to 9.5 milligrams and above the general supplement upper guidance of 25 milligrams. It is acceptable because the course is short, typically under a week.
Swallowing a zinc tablet does not replicate this. The lozenge format matters because the zinc needs to be released in the mouth and throat rather than absorbed in the gut.
Which forms work?
Zinc acetate and zinc gluconate feature most in the successful trials. The key requirement is that the lozenge releases free zinc ions rather than binding them.
Lozenges containing citric acid, tartaric acid, sorbitol or mannitol may bind zinc and reduce the amount available, which is one proposed explanation for why some trials found nothing.
Reading the ingredient list is therefore worth doing, though many commercial products do not make this easy.
What are the downsides?
- The taste is genuinely unpleasant and is the most common complaint
- Nausea and stomach upset are frequent
- A metallic aftertaste that can linger
- Mouth irritation with frequent use
Dropout rates in the trials were high, which tells you something about tolerability. This is not a pleasant intervention.
What about zinc nasal sprays?
These should be avoided. Intranasal zinc gels were associated with cases of anosmia, meaning permanent loss of the sense of smell, and regulators issued warnings before products were withdrawn.
The oral lozenge evidence does not transfer to nasal products, and the risk is not worth taking.
Does zinc prevent colds?
The evidence for prevention is weaker than for treatment. Some trials of ongoing supplementation have suggested modest reductions in cold incidence, mainly in children and in populations with poor zinc status.
Taking high dose zinc continuously is a poor idea regardless, since sustained intakes above roughly 25 milligrams daily interfere with copper absorption and can cause copper deficiency.
Short courses for treatment and long term high dose supplementation are entirely different propositions.
Is it worth trying?
If you have lozenges to hand and start within a day of symptoms, the evidence supports a modest benefit. Expect a shorter cold rather than no cold.
Stop once the cold resolves rather than continuing, and do not take high dose zinc for weeks at a time. Anyone taking antibiotics should check timing with a pharmacist, since zinc binds several of them.
This article is general information and not medical advice.
Why do the trials disagree so much?
Mostly because they were not testing the same thing. Doses ranged from modest to very high, forms varied, and lozenge formulations differed in whether they actually released free zinc ions.
Trials that used low doses or formulations containing binding agents would be expected to find nothing even if zinc works, which makes pooling them together a blunt instrument.